Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJoseph P. Eder, Donald Küfe, Jeffrey W. Clark et al.|Journal of Clinical Oncology|2002Cited by 244